Selvi Durmus
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The level of collaboration amongst nurses in Turkey.
Journal: International nursing review
Published: March 06, 2018
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.
Journal: Oncogene
Published: May 07, 2017
The impact of Organic Anion-Transporting Polypeptides (OATPs) on disposition and toxicity of antitumor drugs: Insights from knockout and humanized mice.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: February 06, 2016
Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Journal: Molecular pharmaceutics
Published: October 18, 2015
P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in Mice.
Journal: Molecular pharmaceutics
Published: August 29, 2015
Cationic Pd(II)/Pt(II) 5,5-diethylbarbiturate complexes with bis(2-pyridylmethyl)amine and terpyridine: Synthesis, structures,DNA/BSA interactions, intracellular distribution, cytotoxic activity and induction of apoptosis.
Journal: Journal of inorganic biochemistry
Published: June 18, 2015
Apical ABC transporters and cancer chemotherapeutic drug disposition.
Journal: Advances in cancer research
Published: February 03, 2015
Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1).
Journal: Pharmaceutical research
Published: September 26, 2014
P-glycoprotein, CYP3A, and plasma carboxylesterase determine brain and blood disposition of the mTOR Inhibitor everolimus (Afinitor) in mice.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 15, 2014
Breast cancer resistance protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) restrict oral availability and brain accumulation of the PARP inhibitor rucaparib (AG-014699).
Journal: Pharmaceutical research
Published: March 10, 2014
Liquid chromatography-tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma.
Journal: Biomedical chromatography : BMC
Published: October 29, 2013
Last Updated: 09/26/2026